News
Merck aims to boost its business by buying Verona Pharma for $10 billion. Through the deal, it will add Ohtuvayre -- a ...
8h
PHILADELPHIA.Today on MSNWSJ: Merck Makes $10 Billion Move as Keytruda Patent Expiration NearsMerck is making big pharma waves again with a $10 billion deal to acquire Verona Pharma, reports Colin Kellaher for the Wall ...
Backed by an initial funding of $15 million from the National Science Foundation, the Regenerative Medicine Engine is the ...
Seven biotech unicorns are advancing AI-powered drug discovery and development—but must contend with a difficult investing ...
Boston conference will explore strategic partnering, device innovation, and delivery solutions for emerging therapeutics.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results